1 week Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue Estimates Zacks

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of -0.58% and 11.76%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?